ConvaTec Group PLC (CTEC) - Total Assets
Based on the latest financial reports, ConvaTec Group PLC (CTEC) holds total assets worth GBX3.77 Billion GBX (≈ $458.88K USD) as of June 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See what is ConvaTec Group PLC's book value for net asset value and shareholders' equity analysis.
ConvaTec Group PLC - Total Assets Trend (2009–2024)
This chart illustrates how ConvaTec Group PLC's total assets have evolved over time, based on quarterly financial data.
ConvaTec Group PLC - Asset Composition Analysis
Current Asset Composition (December 2024)
ConvaTec Group PLC's total assets of GBX3.77 Billion consist of 22.6% current assets and 77.4% non-current assets.
| Asset Category | Amount (GBX) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | GBX0.00 | 1.8% |
| Accounts Receivable | GBX301.00 Million | 8.6% |
| Inventory | GBX349.60 Million | 10.0% |
| Property, Plant & Equipment | GBX0.00 | 0.0% |
| Intangible Assets | GBX805.90 Million | 22.9% |
| Goodwill | GBX1.29 Billion | 36.7% |
Asset Composition Trend (2009–2024)
This chart illustrates how ConvaTec Group PLC's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see CTEC stock market capitalisation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: ConvaTec Group PLC's current assets represent 22.6% of total assets in 2024, an increase from 0.0% in 2009.
- Cash Position: Cash and equivalents constituted 1.8% of total assets in 2024, down from 2.2% in 2009.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 58.0% of total assets, a decrease from 97.0% in 2009.
- Asset Diversification: The largest asset category is goodwill at 36.7% of total assets.
ConvaTec Group PLC Competitors by Total Assets
Key competitors of ConvaTec Group PLC based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
iRay Technology Co Ltd
SHG:688301
|
China | CN¥11.33 Billion |
|
Nanosonics Ltd
AU:NAN
|
Australia | AU$272.48 Million |
|
Jiangsu Nanfang Medical
SHG:603880
|
China | CN¥993.46 Million |
|
MEDIMI AB AK
F:79T
|
Germany | €1.70 Million |
|
Ansell Ltd
AU:ANN
|
Australia | AU$3.32 Billion |
|
SDI Ltd
AU:SDI
|
Australia | AU$141.20 Million |
|
Austco Healthcare Ltd
AU:AHC
|
Australia | AU$91.07 Million |
|
Trajan Group Holdings Ltd
AU:TRJ
|
Australia | AU$192.32 Million |
ConvaTec Group PLC - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.95 | 2.26 | 2.69 |
| Quick Ratio | 1.15 | 1.27 | 1.94 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | GBX455.20 Million | GBX482.30 Million | GBX653.30 Million |
ConvaTec Group PLC - Advanced Valuation Insights
This section examines the relationship between ConvaTec Group PLC's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 3.30 |
| Latest Market Cap to Assets Ratio | 0.01 |
| Asset Growth Rate (YoY) | -5.4% |
| Total Assets | GBX3.52 Billion |
| Market Capitalization | $49.81 Million USD |
Valuation Analysis
Below Book Valuation: The market values ConvaTec Group PLC's assets below their book value (0.01x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: ConvaTec Group PLC's assets decreased by 5.4% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for ConvaTec Group PLC (2009–2024)
The table below shows the annual total assets of ConvaTec Group PLC from 2009 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | GBX3.52 Billion ≈ $427.67K |
-5.35% |
| 2023-12-31 | GBX3.71 Billion ≈ $451.85K |
+3.39% |
| 2022-12-31 | GBX3.59 Billion ≈ $437.04K |
-2.23% |
| 2021-12-31 | GBX3.67 Billion ≈ $447.02K |
-2.46% |
| 2020-12-31 | GBX3.77 Billion ≈ $458.27K |
+4.34% |
| 2019-12-31 | GBX3.61 Billion ≈ $439.21K |
-1.38% |
| 2018-12-31 | GBX3.66 Billion ≈ $445.36K |
-3.70% |
| 2017-12-31 | GBX3.80 Billion ≈ $462.46K |
+8.17% |
| 2016-12-31 | GBX3.51 Billion ≈ $427.54K |
-7.32% |
| 2015-12-31 | GBX3.79 Billion ≈ $461.30K |
-4.33% |
| 2014-12-31 | GBX3.96 Billion ≈ $482.16K |
-13.13% |
| 2013-12-31 | GBX4.56 Billion ≈ $555.04K |
+1.48% |
| 2012-12-31 | GBX4.50 Billion ≈ $546.95K |
+10.39% |
| 2011-12-31 | GBX4.07 Billion ≈ $495.46K |
-3.64% |
| 2010-12-31 | GBX4.23 Billion ≈ $514.18K |
-10.61% |
| 2009-12-31 | GBX4.73 Billion ≈ $575.22K |
-- |
About ConvaTec Group PLC
ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services and technologies in Europe, North America, and internationally. The company offers advanced wound care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. It also provides ostom… Read more